Xponance Inc. Has $768,000 Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Xponance Inc. lifted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 155.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,326 shares of the company's stock after buying an additional 15,418 shares during the period. Xponance Inc.'s holdings in Bath & Body Works were worth $768,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC boosted its position in Bath & Body Works by 38.9% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock worth $1,265,000 after acquiring an additional 11,681 shares during the period. Kovitz Investment Group Partners LLC bought a new stake in shares of Bath & Body Works during the fourth quarter valued at about $258,000. Merit Financial Group LLC acquired a new stake in Bath & Body Works in the first quarter worth about $714,000. Nuveen Asset Management LLC grew its position in Bath & Body Works by 3.7% in the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock valued at $29,628,000 after buying an additional 27,136 shares in the last quarter. Finally, New Age Alpha Advisors LLC acquired a new position in Bath & Body Works during the 4th quarter valued at about $1,350,000. 95.14% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on BBWI. Barclays reduced their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research note on Friday, May 30th. UBS Group upped their target price on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the company an "overweight" rating in a research report on Thursday, May 15th. Morgan Stanley dropped their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 6th. Finally, Wells Fargo & Company raised their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, May 14th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $42.00.

Bath & Body Works Price Performance

BBWI traded up $0.08 on Friday, reaching $31.79. 4,055,265 shares of the company traded hands, compared to its average volume of 5,249,268. The company has a market cap of $6.73 billion, a price-to-earnings ratio of 8.48, a PEG ratio of 1.03 and a beta of 1.72. The stock's 50 day moving average price is $30.15 and its 200-day moving average price is $32.35. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The business had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. Bath & Body Works's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.38 earnings per share. As a group, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.52%. Bath & Body Works's payout ratio is 21.33%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.